Markedsdata leveret af TwelveData og Morningstar
Bio-Gate AG is a Germany-based medical technology company focused on advanced health and hygiene solutions. The company specializes in equipping materials and surfaces with antimicrobial and antiviral properties, primarily through proprietary silver-based technologies. Its portfolio centers on products such as HyProtect, an ultrathin plasma coating that protects medical implants from bacterial colonization, and MicroSilver BG, a microporous elemental silver additive used to provide long-lasting antimicrobial effects. Bio-Gate AG’s technologies are applied across medical implants, wound dressings, dermal cosmetics, veterinary products, and hygiene-sensitive consumer and industrial goods, including paints, plastics, and textiles. Serving large and medium-sized medical technology firms, pharmaceutical distributors, industrial companies, and public sector institutions, Bio-Gate AG plays a specialized role in enhancing infection prevention and product safety throughout the healthcare and hygiene value chain. Founded in 2005 and headquartered in Nuremberg, Germany, the company operates today as a health-technology provider with a strong focus on antimicrobial material enhancement and surface coatings.